Clinical trial
Effect of Doxercalciferol on Endothelial Cell Function in End Stage Renal Disease
NCT00528788 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Doxercalciferol on Endothelial Cell Function in End Stage Renal Disease
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- August 31, 2012
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.